Genscript Biotech Corp (1548)

Hong Kong

Currency in HKD

18.17

+1.87(+11.47%)

Delayed Data·03:03:37

Fair Value

Unlock Value

Day's Range

16.48

18.30

52 wk Range

10.36

19.40

1548 Income Statement

Assess the Genscript Biotech Corp income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 1548 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

490.1

625.7

560.48

594.49

959.53

Total Revenues Growth

aa.aa

+25.39%

+27.67%

-10.42%

+6.07%

+61.4%

Cost Of Revenues

aa.aa

207.58

321.62

289.85

322.36

406.32

Gross Profit

aa.aa

282.52

304.08

270.63

272.13

553.2

Gross Profit Growth

aa.aa

+10.4%

+7.63%

-11%

+0.55%

+103.29%

Gross Profit Margin %

aa.aa

57.65%

48.6%

48.29%

45.77%

57.65%

Other Operating Expenses, Total

aa.aa

661.81

742.06

244.44

262.84

297.96

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+43.73%	+12.13%	-67.06%	+7.53%	+13.36%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	358.4	390.1	52.7	53.79	71.23
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	303.41	351.96	191.74	209.05	226.73
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-379.29

-437.98

26.19

9.28

255.25

Operating Income Growth

aa.aa

-85.43%

-15.47%

+105.98%

-64.56%

+2,649.9%

EBIT Margin %

aa.aa

-77.39%

-70%

4.67%

1.56%

26.6%

Net Interest Expenses

aa.aa

4.17

-0.05

16.85

21.35

8.81

Net Interest Expenses Growth

aa.aa

-36.63%

-101.22%

+33,129.41%

+26.72%

-58.74%

Interest Expense, Total

aa.aa

-2.38

-13.27

-5.74

-8.03

-17.29

Interest And Investment Income

aa.aa

6.55

13.22

22.58

29.38

26.1

Other Non Operating Expenses, Total

aa.aa

-3.52

-0.96

6.54

-32.52

-312.87

EBT, Excl. Unusual Items

aa.aa

-378.63

-438.98

49.58

-1.89

-48.82

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-11.66

-45.51

EBT, Incl. Unusual Items

aa.aa

-517.36

-431.69

168.89

-170.8

-470.53

EBT, Incl. Unusual Items Growth

aa.aa

-83.53%

+16.56%

+139.12%

-201.13%

-175.49%

EBT, Incl. Unusual Items Margin

aa.aa

-105.56%

-68.99%

30.13%

-28.73%

-49.04%

Income Tax Expense

aa.aa

0.96

-3.72

6.01

2.98

61.87

Net Income to Company

aa.aa

-518.33

-427.97

-355.12

2,855.29

-532.4

Minority Interest

aa.aa

159.62

201.12

259.64

106.59

-0.43

Net Income

aa.aa

-358.71

-226.85

-95.48

2,961.88

-532.83

Net Income Growth

aa.aa

-75.03%

+36.76%

+57.91%

+3,202.19%

-117.99%

Net Income Margin %

aa.aa

-73.19%

-36.26%

-17.03%

498.22%

-55.53%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-358.71

-226.85

422.52

-67.18

-532.83

Basic EPS - Continuing Operations

aa.aa

-0.18

-0.11

0.2

-0.03

-0.25

Basic EPS - Continuing Operations Growth

aa.aa

-63.84%

+38.77%

+285.18%

-115.81%

-676.25%

Diluted EPS - Continuing Operations

aa.aa

-0.18

-0.11

0.2

-0.03

-0.25

Diluted EPS - Continuing Operations Growth

aa.aa

-63.88%

+38.77%

+285.09%

-115.81%

-676.25%

Basic Weighted Average Shares Outstanding

aa.aa

2,030.6

2,097.13

2,109.37

2,121.29

2,167.32

Diluted Weighted Average Shares Outstanding

aa.aa

2,030.6

2,097.13

2,109.37

2,178.3

2,191.99

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-341.57

-388.9

83.5

70.04

317.61

EBITDA Growth

aa.aa

-95.51%

-13.86%

+121.47%

-16.12%

+353.49%

EBITDA Margin %

aa.aa

-69.69%

-62.15%

14.9%

11.78%

33.1%

EBIT

aa.aa

-379.29

-437.98

26.19

9.28

255.25

* In Millions of USD (except for per share items)

FAQ

What was Genscript Biotech Corp’s revenue at year end?

At the end of the last reported fiscal year, Genscript Biotech Corp (1548) recorded total revenue of 959.53 million USD.

How much revenue did Genscript Biotech Corp report in the most recent quarter?

In its most recent quarterly earnings report, Genscript Biotech Corp posted revenue of 440.75 million USD.

What was Genscript Biotech Corp’s net income for the year?

For the full year, Genscript Biotech Corp reported net income of -532.83 million USD.

How much net income did Genscript Biotech Corp post in the last quarter?

In the most recent quarter, Genscript Biotech Corp (1548) posted net income of -507.37 million USD.

What was Genscript Biotech Corp’s gross profit for the year?

Gross profit for the year was reported at 553.20 million USD.

How much gross profit did Genscript Biotech Corp generate last quarter?

Genscript Biotech Corp recorded gross profit of 232.57 million USD in its latest quarterly report.

What was Genscript Biotech Corp’s annual operating income?

For the full year, Genscript Biotech Corp (1548) reported operating income of 255.25 million USD.

What was Genscript Biotech Corp’s operating income last quarter?

Quarterly operating income was 76.15 million USD.

What was Genscript Biotech Corp’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 108.68 million USD.

What was the quarter-over-quarter change in EBITDA for Genscript Biotech Corp?

EBITDA changed by -47.98% million USD compared to the last quarter.

How did Genscript Biotech Corp’s revenue change compared to the previous quarter?

Revenue changed by -15.04% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Genscript Biotech Corp?

In the latest quarter, gross profit changed by -27.46% million USD from the previous quarter.

S&P/TSX

35,226.14

-279.70

-0.79%

S&P/TSX 60

2,083.27

-15.80

-0.75%

US 30

53,278.10

+99.7

+0.19%

US 500

7,616.90

+16.4

+0.22%

S&P 500 VIX

15.74

-0.12

-0.76%

DAX

26,232.50

+196.67

+0.76%

Dollar Index

99.87

+0.089

+0.09%

Market Movers

Name	Last	Chg. %	Vol.
RBC	293.41	-0.33%	2.56M
TELUS	13.38	-11.27%	50.34M
Bank of Montreal	251.47	+0.46%	2.34M
Toronto Dominion Bank	168.04	+0.16%	2.85M
Enbridge	76.28	-1.80%	6.03M
Shopify Inc	164.18	-4.28%	2.49M
Bank of Nova Scotia	122.97	-0.11%	2.73M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	25.90K
International Iconic Gold Exploration	0.0150	+200.00%	286.30K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Red Lake Gold	0.0100	+100.00%	20.00K
EnviroMetal Technologies	0.01	+100.00%	1.00K
1933 Industries	0.0100	+100.00%	25.90K
Digicann Ventures	0.010	+100.00%	2.00K

Name	Last	Chg. %	Vol.
Pioneer Media Holdings	0.01	-100.00%	0.00
Lanebury Growth Capital	0.05	-68.75%	18.17K
Champion Electric	0.005	-50.00%	100.00K
BEACN Wizardry Magic	0.03	-50.00%	5.00K
CryptoStar	0.0050	-50.00%	68.70K
Molecule Holdings	0.005	-50.00%	20.11K
Digital Asset Tech	0.01	-50.00%	86.00K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	13.38	-11.27%	50.34M
Keel Infra	5.58	-1.06%	5.45M
Hut 8	151.000	-0.45%	445.58K
Celestica Inc.	463.87	-5.97%	403.37K
Canadian Natural	66.78	+0.85%	4.30M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa	102.61	+52.36%	156.34
Aaaaaaaaaa Aa	5.34	+48.02%	7.90
Aa Aaaaaaaaaaaaaaa	19.84	+47.04%	29.17
Aaaaaa Aaa Aa	144.91	+46.48%	212.26
Aaaaaaaa	35.54	+45.08%	51.56
Aaa Aaa	5.25	+42.81%	7.50
Aaa Aa	19.09	+42.66%	27.23

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa	102.61	+52.36%	156.34
Aaaaaaaaaa Aa	5.34	+48.02%	7.90
Aa Aaaaaaaaaaaaaaa	19.84	+47.04%	29.17
Aaaaaa Aaa Aa	144.91	+46.48%	212.26
Aaaaaaaa	35.54	+45.08%	51.56
Aaa Aaa	5.25	+42.81%	7.50
Aaa Aa	19.09	+42.66%	27.23

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Genscript Biotech Corp (1548)

1548 Income Statement

FAQ

What was Genscript Biotech Corp’s revenue at year end?

How much revenue did Genscript Biotech Corp report in the most recent quarter?

What was Genscript Biotech Corp’s net income for the year?

How much net income did Genscript Biotech Corp post in the last quarter?

What was Genscript Biotech Corp’s gross profit for the year?

How much gross profit did Genscript Biotech Corp generate last quarter?

What was Genscript Biotech Corp’s annual operating income?

What was Genscript Biotech Corp’s operating income last quarter?

What was Genscript Biotech Corp’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Genscript Biotech Corp?

How did Genscript Biotech Corp’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Genscript Biotech Corp?

Trending Stocks